Towards a Clinically Relevant Lentiviral Transduction Protocol for Primary Human CD34 + Hematopoietic Stem/Progenitor Cells

Michelle Millington, Allison Arndt, Maureen Boyd et al. · 2009

Read Towards a Clinically Relevant Lentiviral Transduction Protocol for Primary Human CD34 + Hematopoietic Stem/Progenitor Cells by Michelle Millington, Allison Arndt, Maureen Boyd et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006461.txt.

Description

Michelle Millington and co-authors refined gene delivery into blood stem cells for PLOS ONE in 2009. Blood-forming stem cells, especially those drawn from peripheral blood, are attractive targets for cell and gene therapy. Getting new genes into them with lentiviruses can work well. The catch is doing so without harming their ability to renew themselves and make all blood cell types.

The team worked toward a transduction protocol fit for clinical use. Their focus was primary human CD34 positive stem and progenitor cells. A clinic-ready protocol must be both efficient and gentle. Progress here brings gene therapy for blood diseases closer to routine care.

Catalog record

CREATORMichelle Millington, Allison Arndt, Maureen Boyd et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE49 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006461

Browse the full library · About the Tower of Babel